{"transactions":[{"id":4629711,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-05T20:04:56.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":544,"price":94.35,"value":51326.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":25929,"source":{"system":"sec-edgar","filing":"0001754648-26-000015","document":"wk-form4_1791230692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754648/000175464826000015/wk-form4_1791230692.xml","form_type":"4"}},{"id":4614503,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-10T20:02:04.000Z","date":"2026-09-08","kind":"grant","planned":false,"acquired":true,"shares":157,"price":95.5,"value":14993.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc.\ncommon stock that have become payable, but receipt of which the director has deferred."}],"balance_after":25385,"source":{"system":"sec-edgar","filing":"0001754648-26-000013","document":"wk-form4_1789070521.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754648/000175464826000013/wk-form4_1789070521.xml","form_type":"4"}},{"id":732684,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T20:12:36.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":587,"price":87.4,"value":51303.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":25229,"source":{"system":"sec-edgar","filing":"0001754648-26-000011","document":"wk-form4_1781813553.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000175464826000011/wk-form4_1781813553.xml","form_type":"4"}},{"id":742196,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T20:02:52.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":169,"price":85.57,"value":14461.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc.\ncommon stock that have become payable, but receipt of which the director has deferred."}],"balance_after":24642,"source":{"system":"sec-edgar","filing":"0001754648-26-000009","document":"wk-form4_1781208168.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000175464826000009/wk-form4_1781208168.xml","form_type":"4"}},{"id":749668,"issuer":{"id":4698,"kind":"organization","name":"agilon health, inc."},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T01:56:15.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":2133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units."}],"balance_after":7633,"source":{"system":"sec-edgar","filing":"0001628280-26-041022","document":"wk-form4_1780624572.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754648/000162828026041022/wk-form4_1780624572.xml","form_type":"4"}},{"id":310074,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2026-05-05T21:18:16.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":796,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon the vesting of restricted stock units granted to Ms. McKenzie on May 1, 2025, Ms. McKenzie deferred the receipt of 796 shares of common stock and received instead 796 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. McKenzie is reporting the disposition of 796 shares of common stock in exchange for an equal number of deferred stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."}],"balance_after":7787.483,"derivative":{"underlying":"Common Stock","underlying_shares":796},"source":{"system":"sec-edgar","filing":"0000875320-26-000185","document":"wk-form4_1778015893.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000185/wk-form4_1778015893.xml","form_type":"4"}},{"id":310073,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-05T21:18:16.000Z","date":"2026-05-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":796,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon the vesting of restricted stock units granted to Ms. McKenzie on May 1, 2025, Ms. McKenzie deferred the receipt of 796 shares of common stock and received instead 796 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. McKenzie is reporting the disposition of 796 shares of common stock in exchange for an equal number of deferred stock units."}],"balance_after":2378,"source":{"system":"sec-edgar","filing":"0000875320-26-000185","document":"wk-form4_1778015893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000185/wk-form4_1778015893.xml","form_type":"4"}},{"id":310072,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-05T21:18:16.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":943,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":3174,"source":{"system":"sec-edgar","filing":"0000875320-26-000185","document":"wk-form4_1778015893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000185/wk-form4_1778015893.xml","form_type":"4"}},{"id":817491,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-03T20:04:31.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":721,"price":71.17,"value":51313.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":24472,"source":{"system":"sec-edgar","filing":"0001754648-26-000007","document":"wk-form4_1775246668.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000175464826000007/wk-form4_1775246668.xml","form_type":"4"}},{"id":847026,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-12T20:08:00.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":189,"price":70.6,"value":13343.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc.\ncommon stock that have become payable, but receipt of which the director has deferred."}],"balance_after":23751,"source":{"system":"sec-edgar","filing":"0001754648-26-000005","document":"wk-form4_1773346077.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000175464826000005/wk-form4_1773346077.xml","form_type":"4"}},{"id":948225,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T21:10:20.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":639,"price":80.32,"value":51324.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":23562,"source":{"system":"sec-edgar","filing":"0001754648-26-000003","document":"wk-form4_1767733807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000175464826000003/wk-form4_1767733807.xml","form_type":"4"}},{"id":973173,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-11T21:02:29.000Z","date":"2025-12-09","kind":"grant","planned":false,"acquired":true,"shares":166,"price":77.82,"value":12918.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc.\ncommon stock that have become payable, but receipt of which the director has deferred."}],"balance_after":22923,"source":{"system":"sec-edgar","filing":"0001754648-25-000006","document":"wk-form4_1765486946.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000175464825000006/wk-form4_1765486946.xml","form_type":"4"}},{"id":1025490,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:02:59.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":534,"price":81.93,"value":43750.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":22757,"source":{"system":"sec-edgar","filing":"0001754648-25-000004","document":"wk-form4_1759521776.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000175464825000004/wk-form4_1759521776.xml","form_type":"4"}},{"id":1043264,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T20:02:37.000Z","date":"2025-09-09","kind":"grant","planned":false,"acquired":true,"shares":158,"price":79.29,"value":12527.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc.\ncommon stock that have become payable, but receipt of which the director has deferred."}],"balance_after":22223,"source":{"system":"sec-edgar","filing":"0001099219-25-000216","document":"wk-form4_1757620953.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921925000216/wk-form4_1757620953.xml","form_type":"4"}},{"id":1105404,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-20T20:32:22.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":562,"price":77.85,"value":43751.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":22065,"source":{"system":"sec-edgar","filing":"0001099219-25-000179","document":"wk-form4_1750451534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921925000179/wk-form4_1750451534.xml","form_type":"4"}},{"id":1114105,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T20:21:12.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":153,"price":79.43,"value":12152.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc.\ncommon stock that have become payable, but receipt of which the director has deferred."}],"balance_after":21503,"source":{"system":"sec-edgar","filing":"0001099219-25-000158","document":"wk-form4_1749759664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921925000158/wk-form4_1749759664.xml","form_type":"4"}},{"id":1129311,"issuer":{"id":4698,"kind":"organization","name":"agilon health, inc."},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-30T23:39:34.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":78724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that vest in full on May 28, 2026, subject to continued service as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":137543,"source":{"system":"sec-edgar","filing":"0001628280-25-028721","document":"wk-form4_1748648358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754648/000162828025028721/wk-form4_1748648358.xml","form_type":"4"}},{"id":322559,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2025-05-05T20:52:27.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":1001,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon the vesting of restricted stock units granted to Ms. McKenzie on May 1, 2024, Ms. McKenzie deferred the receipt of 1,001 shares of common stock and received instead 1,001 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. McKenzie is reporting the disposition of 1,001 shares of common stock in exchange for an equal number of deferred stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."}],"balance_after":6991.483,"derivative":{"underlying":"Common Stock","underlying_shares":1001},"source":{"system":"sec-edgar","filing":"0000875320-25-000182","document":"wk-form4_1746478338.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000182/wk-form4_1746478338.xml","form_type":"4"}},{"id":322558,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-05T20:52:27.000Z","date":"2025-05-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1001,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon the vesting of restricted stock units granted to Ms. McKenzie on May 1, 2024, Ms. McKenzie deferred the receipt of 1,001 shares of common stock and received instead 1,001 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. McKenzie is reporting the disposition of 1,001 shares of common stock in exchange for an equal number of deferred stock units."}],"balance_after":2231,"source":{"system":"sec-edgar","filing":"0000875320-25-000182","document":"wk-form4_1746478338.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000182/wk-form4_1746478338.xml","form_type":"4"}},{"id":322557,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-05T20:52:27.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":3232,"source":{"system":"sec-edgar","filing":"0000875320-25-000182","document":"wk-form4_1746478338.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000182/wk-form4_1746478338.xml","form_type":"4"}},{"id":1180715,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-03T20:27:17.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":540,"price":81.16,"value":43826.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":21350,"source":{"system":"sec-edgar","filing":"0001099219-25-000111","document":"wk-form4_1743712031.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921925000111/wk-form4_1743712031.xml","form_type":"4"}},{"id":1208300,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-13T20:19:15.000Z","date":"2025-03-11","kind":"grant","planned":false,"acquired":true,"shares":144,"price":78.45,"value":11296.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred."}],"balance_after":20810,"source":{"system":"sec-edgar","filing":"0001099219-25-000094","document":"wk-form4_1741897149.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921925000094/wk-form4_1741897149.xml","form_type":"4"}},{"id":1311689,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-06T21:40:07.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":535,"price":81.78,"value":43752.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":20667,"source":{"system":"sec-edgar","filing":"0001099219-25-000026","document":"wk-form4_1736199599.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921925000026/wk-form4_1736199599.xml","form_type":"4"}},{"id":1327266,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-18T21:33:21.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":132,"price":82.74,"value":10921.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred."}],"balance_after":20132,"source":{"system":"sec-edgar","filing":"0001099219-24-000284","document":"wk-form4_1734557595.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921924000284/wk-form4_1734557595.xml","form_type":"4"}},{"id":1335753,"issuer":{"id":4698,"kind":"organization","name":"agilon health, inc."},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-11T22:25:11.000Z","date":"2024-12-09","kind":"purchase","planned":false,"acquired":true,"shares":7500,"price":2.1985,"value":16488.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $2.1942 to $2.2050, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units."}],"balance_after":58819,"source":{"system":"sec-edgar","filing":"0001628280-24-050832","document":"wk-form4_1733955904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754648/000162828024050832/wk-form4_1733955904.xml","form_type":"4"}},{"id":1335752,"issuer":{"id":4698,"kind":"organization","name":"agilon health, inc."},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-11T22:25:11.000Z","date":"2024-11-25","kind":"purchase","planned":false,"acquired":true,"shares":12500,"price":2.2779,"value":28473.75,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units."}],"balance_after":51319,"source":{"system":"sec-edgar","filing":"0001628280-24-050832","document":"wk-form4_1733955904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754648/000162828024050832/wk-form4_1733955904.xml","form_type":"4"}},{"id":1392644,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-03T20:15:53.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":535,"price":81.78,"value":43752.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.  The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001099219-24-000243","document":"wk-form4_1727986546.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921924000243/wk-form4_1727986546.xml","form_type":"4"}},{"id":1409092,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-12T20:32:22.000Z","date":"2024-09-10","kind":"grant","planned":false,"acquired":true,"shares":141,"price":74.63,"value":10522.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred."}],"balance_after":19465,"source":{"system":"sec-edgar","filing":"0001099219-24-000223","document":"wk-form4_1726173134.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921924000223/wk-form4_1726173134.xml","form_type":"4"}},{"id":1473816,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-20T20:38:10.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":627,"price":69.86,"value":43802.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.  The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":19324,"source":{"system":"sec-edgar","filing":"0001099219-24-000185","document":"wk-form4_1718915883.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921924000185/wk-form4_1718915883.xml","form_type":"4"}},{"id":1481210,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-13T20:20:55.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":146,"price":69.06,"value":10082.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred."}],"balance_after":18697,"source":{"system":"sec-edgar","filing":"0001099219-24-000161","document":"wk-form4_1718310046.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921924000161/wk-form4_1718310046.xml","form_type":"4"}},{"id":1496748,"issuer":{"id":4698,"kind":"organization","name":"agilon health, inc."},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-01T00:56:47.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":32119,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that vest in full on May 29, 2025, subject to continued service as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":38819,"source":{"system":"sec-edgar","filing":"0001628280-24-026128","document":"wk-form4_1717203400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754648/000162828024026128/wk-form4_1717203400.xml","form_type":"4"}},{"id":334162,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2024-05-03T20:18:35.000Z","date":"2024-05-01","kind":"grant","planned":false,"acquired":true,"shares":1168,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon the vesting of restricted stock units granted to Ms. McKenzie on May 1, 2023, Ms. McKenzie deferred the receipt of 1,168 shares of common stock and received instead 1,168 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. McKenzie is reporting the disposition of 1,168 shares of common stock in exchange for an equal number of deferred stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."}],"balance_after":5990.483,"derivative":{"underlying":"Common Stock","underlying_shares":1168},"source":{"system":"sec-edgar","filing":"0000875320-24-000127","document":"wk-form4_1714767498.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000127/wk-form4_1714767498.xml","form_type":"4"}},{"id":334161,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-03T20:18:35.000Z","date":"2024-05-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1168,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Upon the vesting of restricted stock units granted to Ms. McKenzie on May 1, 2023, Ms. McKenzie deferred the receipt of 1,168 shares of common stock and received instead 1,168 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. McKenzie is reporting the disposition of 1,168 shares of common stock in exchange for an equal number of deferred stock units."}],"balance_after":2436,"source":{"system":"sec-edgar","filing":"0000875320-24-000127","document":"wk-form4_1714767498.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000127/wk-form4_1714767498.xml","form_type":"4"}},{"id":334160,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-03T20:18:35.000Z","date":"2024-05-01","kind":"grant","planned":false,"acquired":true,"shares":1001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":3604,"source":{"system":"sec-edgar","filing":"0000875320-24-000127","document":"wk-form4_1714767498.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000127/wk-form4_1714767498.xml","form_type":"4"}},{"id":1551049,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-03T20:20:42.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":594,"price":73.69,"value":43771.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.  The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":18550,"source":{"system":"sec-edgar","filing":"0001099219-24-000118","document":"wk-form4_1712175628.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921924000118/wk-form4_1712175628.xml","form_type":"4"}},{"id":1573367,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-18T20:48:28.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":129,"price":71.9,"value":9275.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred."}],"balance_after":17956,"source":{"system":"sec-edgar","filing":"0001099219-24-000090","document":"wk-form4_1710794889.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921924000090/wk-form4_1710794889.xml","form_type":"4"}},{"id":342432,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2024-01-17T21:05:59.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":76.503,"price":432.99,"value":33125.03397,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."}],"balance_after":4822.483,"derivative":{"underlying":"Common Stock","underlying_shares":76.503},"source":{"system":"sec-edgar","filing":"0000875320-24-000006","document":"wk-form4_1705525544.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000006/wk-form4_1705525544.xml","form_type":"4"}},{"id":1688979,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T21:40:25.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":650,"price":67.35,"value":43777.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.  The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":17828,"source":{"system":"sec-edgar","filing":"0001099219-24-000024","document":"wk-form4_1704404290.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921924000024/wk-form4_1704404290.xml","form_type":"4"}},{"id":1707986,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-18T22:19:28.000Z","date":"2023-12-14","kind":"grant","planned":false,"acquired":true,"shares":132,"price":66.9,"value":8830.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred."}],"balance_after":17178,"source":{"system":"sec-edgar","filing":"0001099219-23-000291","document":"wk-form4_1702937959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921923000291/wk-form4_1702937959.xml","form_type":"4"}},{"id":345190,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2023-10-17T20:17:23.000Z","date":"2023-10-13","kind":"grant","planned":false,"acquired":true,"shares":89.532,"price":369.98,"value":33125.04936,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."}],"balance_after":4745.98,"derivative":{"underlying":"Common Stock","underlying_shares":89.532},"source":{"system":"sec-edgar","filing":"0001209191-23-052959","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123052959/doc4.xml","form_type":"4"}},{"id":1765814,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-04T20:36:24.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":710,"price":61.69,"value":43799.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.  The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":17045,"source":{"system":"sec-edgar","filing":"0001099219-23-000260","document":"wk-form4_1696451772.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921923000260/wk-form4_1696451772.xml","form_type":"4"}},{"id":1779373,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-18T20:29:14.000Z","date":"2023-09-14","kind":"grant","planned":false,"acquired":true,"shares":128,"price":65.93,"value":8439.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred."}],"balance_after":16335,"source":{"system":"sec-edgar","filing":"0001099219-23-000233","document":"wf-form4_169506894098524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921923000233/wf-form4_169506894098524.xml","form_type":"4"}},{"id":347486,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2023-07-18T20:14:59.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":89.927,"price":350.79,"value":31545.49233,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."}],"balance_after":4656.448,"derivative":{"underlying":"Common Stock","underlying_shares":89.927},"source":{"system":"sec-edgar","filing":"0001209191-23-042563","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123042563/doc4.xml","form_type":"4"}},{"id":1846929,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-22T20:17:39.000Z","date":"2023-06-20","kind":"grant","planned":false,"acquired":true,"shares":803,"price":54.52,"value":43779.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.  The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":16207,"source":{"system":"sec-edgar","filing":"0001099219-23-000192","document":"wf-form4_168746504163208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921923000192/wf-form4_168746504163208.xml","form_type":"4"}},{"id":1853088,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:16:36.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":147,"price":53.94,"value":7929.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred."}],"balance_after":15404,"source":{"system":"sec-edgar","filing":"0001099219-23-000169","document":"wf-form4_168694657956037.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921923000169/wf-form4_168694657956037.xml","form_type":"4"}},{"id":349491,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2023-05-03T21:01:58.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":1449,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the vesting of restricted stock units granted to Ms. McKenzie on May 1, 2022, Ms. McKenzie deferred the receipt of 1,449 shares of common stock and received instead 1,449 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. McKenzie is reporting the disposition of 1,449 shares of common stock in exchange for an equal number of deferred stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."}],"balance_after":4566.521,"derivative":{"underlying":"Common Stock","underlying_shares":1449},"source":{"system":"sec-edgar","filing":"0001209191-23-027051","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123027051/doc4.xml","form_type":"4"}},{"id":349490,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-03T21:01:58.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":1168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":2603,"source":{"system":"sec-edgar","filing":"0001209191-23-027051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123027051/doc4.xml","form_type":"4"}},{"id":349489,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-03T21:01:58.000Z","date":"2023-05-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1449,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the vesting of restricted stock units granted to Ms. McKenzie on May 1, 2022, Ms. McKenzie deferred the receipt of 1,449 shares of common stock and received instead 1,449 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. McKenzie is reporting the disposition of 1,449 shares of common stock in exchange for an equal number of deferred stock units."}],"balance_after":1435,"source":{"system":"sec-edgar","filing":"0001209191-23-027051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123027051/doc4.xml","form_type":"4"}},{"id":350068,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2023-04-18T21:09:18.000Z","date":"2023-04-14","kind":"grant","planned":false,"acquired":true,"shares":90.153,"price":332.77,"value":30000.21381,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."}],"balance_after":3117.521,"derivative":{"underlying":"Common Stock","underlying_shares":90.153},"source":{"system":"sec-edgar","filing":"0001209191-23-024705","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123024705/doc4.xml","form_type":"4"}},{"id":1918174,"issuer":{"id":4698,"kind":"organization","name":"agilon health, inc."},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-18T20:48:12.000Z","date":"2023-04-14","kind":"grant","planned":false,"acquired":true,"shares":5622,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that vest in full on April 14, 2024, subject to continued service as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units."}],"balance_after":6700,"source":{"system":"sec-edgar","filing":"0001209191-23-024672","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754648/000120919123024672/doc4.xml","form_type":"4"}},{"id":1925706,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-05T21:04:25.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":755,"price":57.97,"value":43767.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.  The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":15257,"source":{"system":"sec-edgar","filing":"0001099219-23-000137","document":"wf-form4_168072865289910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921923000137/wf-form4_168072865289910.xml","form_type":"4"}},{"id":1950780,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-16T20:36:08.000Z","date":"2023-03-14","kind":"grant","acquired":true,"shares":121,"price":59.07,"value":7147.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred."}],"balance_after":14502,"source":{"system":"sec-edgar","filing":"0001099219-23-000108","document":"wf-form4_167899895118897.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921923000108/wf-form4_167899895118897.xml","form_type":"4"}},{"id":1980786,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-03T00:03:46.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":31,"price":71.73,"value":2223.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.  The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":14381,"source":{"system":"sec-edgar","filing":"0001099219-23-000089","document":"wf-form4_167780180660073.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921923000089/wf-form4_167780180660073.xml","form_type":"4"}},{"id":2000040,"issuer":{"id":4698,"kind":"organization","name":"agilon health, inc."},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Rights to Buy)","published_at":"2023-02-22T22:20:06.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":11104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options that vest in three equal installments on each anniversary of February 17, 2023, subject to continued service as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Options that vest in three equal installments on each anniversary of February 17, 2023, subject to continued service as a director."}],"balance_after":11104,"derivative":{"exercise_price":22.79,"expiration_date":"2033-02-17","underlying":"Common Stock","underlying_shares":11104},"source":{"system":"sec-edgar","filing":"0001209191-23-011763","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754648/000120919123011763/doc4.xml","form_type":"4"}},{"id":2000039,"issuer":{"id":4698,"kind":"organization","name":"agilon health, inc."},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-22T22:20:06.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":1078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that vest in full on February 17, 2024, subject to continued service as a director."}],"balance_after":1078,"source":{"system":"sec-edgar","filing":"0001209191-23-011763","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754648/000120919123011763/doc4.xml","form_type":"4"}},{"id":354798,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2023-01-18T21:07:33.000Z","date":"2023-01-13","kind":"grant","acquired":true,"shares":100.53,"price":298.42,"value":30000.1626,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."}],"balance_after":3027.368,"derivative":{"underlying":"Common Stock","underlying_shares":100.53},"source":{"system":"sec-edgar","filing":"0001209191-23-003703","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123003703/doc4.xml","form_type":"4"}},{"id":2063806,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T21:27:50.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":520,"price":72.15,"value":37518.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer in MetLife, Inc. common stock.  The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":14350,"source":{"system":"sec-edgar","filing":"0001099219-23-000027","document":"wf-form4_167295405353494.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921923000027/wf-form4_167295405353494.xml","form_type":"4"}},{"id":2084214,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-16T21:25:18.000Z","date":"2022-12-14","kind":"grant","acquired":true,"shares":94,"price":72.84,"value":6846.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred."}],"balance_after":13830,"source":{"system":"sec-edgar","filing":"0001099219-22-000203","document":"wf-form4_167122589949781.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921922000203/wf-form4_167122589949781.xml","form_type":"4"}},{"id":357459,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2022-10-18T20:25:32.000Z","date":"2022-10-14","kind":"grant","acquired":true,"shares":101.072,"price":296.82,"value":30000.19104,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."}],"balance_after":2926.838,"derivative":{"underlying":"Common Stock","underlying_shares":101.072},"source":{"system":"sec-edgar","filing":"0000899243-22-033743","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322033743/doc4.xml","form_type":"4"}},{"id":2142289,"issuer":{"id":15437,"kind":"organization","name":"Change Healthcare Inc.","symbol":"CHNG"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-05T20:31:31.000Z","date":"2022-10-03","kind":"disposition_to_issuer","acquired":false,"shares":40706,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 3, 2022, UnitedHealth Group Incorporated (\"UnitedHealth Group\") acquired Change Healthcare Inc. (the \"Issuer\") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the \"Merger Agreement\") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group (\"Merger Sub\"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the \"Effective Time\"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the \"Common Stock\") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash, without interest and less any applicable holding tax."},{"field":"shares","element":"transactionShares","label":"F2","text":"At the Effective Time of the Merger, all deferred stock units of the Issuer automatically vested and were automatically converted into UnitedHealth Group deferred stock units calculated by taking the merger consideration of $25.75 per share of Common Stock and dividing it by the volume weighted average of the closing sale prices per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer deferred stock units."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 3, 2022, UnitedHealth Group Incorporated (\"UnitedHealth Group\") acquired Change Healthcare Inc. (the \"Issuer\") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the \"Merger Agreement\") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group (\"Merger Sub\"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the \"Effective Time\"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the \"Common Stock\") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash, without interest and less any applicable holding tax."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time of the Merger, all deferred stock units of the Issuer automatically vested and were automatically converted into UnitedHealth Group deferred stock units calculated by taking the merger consideration of $25.75 per share of Common Stock and dividing it by the volume weighted average of the closing sale prices per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer deferred stock units."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-033009","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754648/000089924322033009/doc4.xml","form_type":"4"}},{"id":2142739,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-05T20:28:58.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":599,"price":62.62,"value":37509.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock.  The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":13735,"source":{"system":"sec-edgar","filing":"0001099219-22-000166","document":"wf-form4_166500172332928.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921922000166/wf-form4_166500172332928.xml","form_type":"4"}},{"id":2157692,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-16T20:26:10.000Z","date":"2022-09-14","kind":"grant","acquired":true,"shares":98,"price":66.41,"value":6508.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred."}],"balance_after":13136,"source":{"system":"sec-edgar","filing":"0001099219-22-000144","document":"wf-form4_166335995531873.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921922000144/wf-form4_166335995531873.xml","form_type":"4"}},{"id":359708,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2022-07-19T20:33:32.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":95.081,"price":289.23,"value":27500.27763,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."}],"balance_after":2825.766,"derivative":{"underlying":"Common Stock","underlying_shares":95.081},"source":{"system":"sec-edgar","filing":"0000899243-22-026342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322026342/doc4.xml","form_type":"4"}},{"id":2223342,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-23T20:14:56.000Z","date":"2022-06-21","kind":"grant","acquired":true,"shares":600,"price":62.53,"value":37518.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock.  The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":13038,"source":{"system":"sec-edgar","filing":"0000937834-22-000081","document":"wf-form4_165601528143631.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000093783422000081/wf-form4_165601528143631.xml","form_type":"4"}},{"id":2230488,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-16T20:29:02.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":100,"price":61.86,"value":6186.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred."}],"balance_after":12438,"source":{"system":"sec-edgar","filing":"0000937834-22-000054","document":"wf-form4_165541132413217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000093783422000054/wf-form4_165541132413217.xml","form_type":"4"}},{"id":361989,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2022-05-03T20:48:53.000Z","date":"2022-05-01","kind":"grant","acquired":true,"shares":1842,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on the Issuer's board of directors, (ii) a change of control of the Issuer and (iii) Ms. McKenzie's disability or death."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the vesting of restricted stock units granted to Ms. McKenzie on May 1, 2021, Ms. McKenzie deferred the receipt of 1,842 shares of common stock and received instead 1,842 deferred stock units pursuant to the Issuer's deferred compensation plan. As a result, Ms. McKenzie is reporting the disposition of 1,842 shares of common stock in exchange for an equal number of deferred stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on the Issuer's board of directors, (ii) a change of control of the Issuer and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on the Issuer's board of directors, (ii) a change of control of the Issuer and (iii) Ms. McKenzie's disability or death."}],"balance_after":2730.685,"derivative":{"underlying":"Common Stock","underlying_shares":1842},"source":{"system":"sec-edgar","filing":"0000899243-22-016338","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016338/doc4.xml","form_type":"4"}},{"id":361988,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-03T20:48:53.000Z","date":"2022-05-01","kind":"grant","acquired":true,"shares":1449,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":2884,"source":{"system":"sec-edgar","filing":"0000899243-22-016338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016338/doc4.xml","form_type":"4"}},{"id":361987,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-03T20:48:53.000Z","date":"2022-05-01","kind":"disposition_to_issuer","acquired":false,"shares":1842,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the vesting of restricted stock units granted to Ms. McKenzie on May 1, 2021, Ms. McKenzie deferred the receipt of 1,842 shares of common stock and received instead 1,842 deferred stock units pursuant to the Issuer's deferred compensation plan. As a result, Ms. McKenzie is reporting the disposition of 1,842 shares of common stock in exchange for an equal number of deferred stock units."}],"balance_after":1435,"source":{"system":"sec-edgar","filing":"0000899243-22-016338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016338/doc4.xml","form_type":"4"}},{"id":2289687,"issuer":{"id":15437,"kind":"organization","name":"Change Healthcare Inc.","symbol":"CHNG"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-27T21:07:39.000Z","date":"2022-04-25","kind":"grant","acquired":true,"shares":7658,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of deferred stock units that vest on April 25, 2023. The shares subject to the units will be issued to the Reporting Person after the Reporting Person's separation from service from the Issuer."}],"balance_after":40706,"source":{"system":"sec-edgar","filing":"0001062993-22-010883","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754648/000106299322010883/form4.xml","form_type":"4"}},{"id":362647,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2022-04-18T20:05:14.000Z","date":"2022-04-14","kind":"grant","acquired":true,"shares":95.021,"price":289.41,"value":27500.02761,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."}],"balance_after":888.685,"derivative":{"underlying":"Common Stock","underlying_shares":95.021},"source":{"system":"sec-edgar","filing":"0000899243-22-014961","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322014961/doc4.xml","form_type":"4"}},{"id":2305596,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T20:09:58.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":532,"price":70.5,"value":37506.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock.  The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":12338,"source":{"system":"sec-edgar","filing":"0001099219-22-000094","document":"wf-form4_164918937600679.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921922000094/wf-form4_164918937600679.xml","form_type":"4"}},{"id":2331509,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-16T20:37:18.000Z","date":"2022-03-14","kind":"grant","acquired":true,"shares":87,"price":64.69,"value":5628.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred."}],"balance_after":11806,"source":{"system":"sec-edgar","filing":"0001099219-22-000074","document":"wf-form4_164746302367165.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921922000074/wf-form4_164746302367165.xml","form_type":"4"}},{"id":367343,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2022-01-19T21:21:25.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":119.265,"price":230.58,"value":27500.1237,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."}],"balance_after":793.664,"derivative":{"underlying":"Common Stock","underlying_shares":119.265},"source":{"system":"sec-edgar","filing":"0001209191-22-003717","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122003717/doc4.xml","form_type":"4"}},{"id":2445331,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:38:38.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":594,"price":63.23,"value":37558.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock.  The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":11720,"source":{"system":"sec-edgar","filing":"0000937834-22-000012","document":"wf-form4_164141870397495.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000093783422000012/wf-form4_164141870397495.xml","form_type":"4"}},{"id":2470404,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-16T21:33:36.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":87,"price":60.8,"value":5289.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred."}],"balance_after":11126,"source":{"system":"sec-edgar","filing":"0001099219-21-000351","document":"wf-form4_163969039629364.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921921000351/wf-form4_163969039629364.xml","form_type":"4"}},{"id":370570,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2021-10-18T20:06:47.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":151.041,"price":182.07,"value":27500.03487,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."}],"balance_after":674.399,"derivative":{"underlying":"Common Stock","underlying_shares":151.041},"source":{"system":"sec-edgar","filing":"0001209191-21-060704","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121060704/doc4.xml","form_type":"4"}},{"id":2549919,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-05T20:29:42.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":600,"price":62.52,"value":37512.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock.  The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":11038,"source":{"system":"sec-edgar","filing":"0001099219-21-000322","document":"wf-form4_163346576952504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921921000322/wf-form4_163346576952504.xml","form_type":"4"}},{"id":2568252,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-16T20:39:22.000Z","date":"2021-09-14","kind":"grant","acquired":true,"shares":82,"price":60.78,"value":4983.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred."}],"balance_after":10438,"source":{"system":"sec-edgar","filing":"0001099219-21-000294","document":"wf-form4_163182473735592.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921921000294/wf-form4_163182473735592.xml","form_type":"4"}},{"id":373512,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2021-07-16T20:06:47.000Z","date":"2021-07-15","kind":"grant","acquired":true,"shares":138.889,"price":198,"value":27500.022,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."}],"balance_after":523.358,"derivative":{"underlying":"Common Stock","underlying_shares":138.889},"source":{"system":"sec-edgar","filing":"0001209191-21-046901","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121046901/doc4.xml","form_type":"4"}},{"id":2655943,"issuer":{"id":15437,"kind":"organization","name":"Change Healthcare Inc.","symbol":"CHNG"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-24T18:26:49.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":7136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of deferred stock units that vests on June 22, 2022. The shares subject to the units will be issued to the Reporting Person after the Reporting Person's separation from service from the Issuer."}],"balance_after":33048,"source":{"system":"sec-edgar","filing":"0001062993-21-005917","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754648/000106299321005917/form4.xml","form_type":"4"}},{"id":2664650,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-17T21:19:05.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":589,"price":63.77,"value":37560.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock.  The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":10357,"source":{"system":"sec-edgar","filing":"0001099219-21-000248","document":"wf-form4_162396470105710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921921000248/wf-form4_162396470105710.xml","form_type":"4"}},{"id":2666959,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-17T00:58:11.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":73,"price":63.31,"value":4621.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred."}],"balance_after":9768,"source":{"system":"sec-edgar","filing":"0001099219-21-000216","document":"wf-form4_162389147905274.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921921000216/wf-form4_162389147905274.xml","form_type":"4"}},{"id":376074,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-04T20:18:34.000Z","date":"2021-05-01","kind":"grant","acquired":true,"shares":1842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":3277,"source":{"system":"sec-edgar","filing":"0001209191-21-029865","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121029865/doc4.xml","form_type":"4"}},{"id":376770,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2021-04-16T20:03:28.000Z","date":"2021-04-15","kind":"grant","acquired":true,"shares":124.904,"price":220.17,"value":27500.11368,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."}],"balance_after":384.469,"derivative":{"underlying":"Common Stock","underlying_shares":124.904},"source":{"system":"sec-edgar","filing":"0001209191-21-026940","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121026940/doc4.xml","form_type":"4"}},{"id":2758839,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-05T20:58:24.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":609,"price":61.6,"value":37514.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock.  The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":9695,"source":{"system":"sec-edgar","filing":"0001099219-21-000161","document":"wf-form4_161765623642029.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921921000161/wf-form4_161765623642029.xml","form_type":"4"}},{"id":2783755,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-17T20:59:20.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":69,"price":60.54,"value":4177.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred."}],"balance_after":9086,"source":{"system":"sec-edgar","filing":"0001099219-21-000130","document":"wf-form4_161601474458010.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921921000130/wf-form4_161601474458010.xml","form_type":"4"}},{"id":381577,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2021-01-19T21:41:32.000Z","date":"2021-01-15","kind":"grant","acquired":true,"shares":121.086,"price":225.99,"value":27364.22514,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."}],"balance_after":259.565,"derivative":{"underlying":"Common Stock","underlying_shares":121.086},"source":{"system":"sec-edgar","filing":"0001209191-21-004031","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121004031/doc4.xml","form_type":"4"}},{"id":2922384,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T21:32:22.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":814,"price":46.08,"value":37509.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock.  The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors."}],"balance_after":9017,"source":{"system":"sec-edgar","filing":"0001099219-21-000031","document":"wf-form4_160988226364740.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921921000031/wf-form4_160988226364740.xml","form_type":"4"}},{"id":2943218,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T22:07:45.000Z","date":"2020-12-14","kind":"grant","acquired":true,"shares":81,"price":45.84,"value":3713.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents imputed reinvestment of dividends on deferred shares in the reporting person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred."}],"balance_after":8203,"source":{"system":"sec-edgar","filing":"0001099219-20-000384","document":"wf-form4_160815645124539.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921920000384/wf-form4_160815645124539.xml","form_type":"4"}},{"id":384810,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2020-10-19T20:13:59.000Z","date":"2020-10-15","kind":"grant","acquired":true,"shares":112.204,"price":222.81,"value":25000.17324,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."}],"balance_after":138.479,"derivative":{"underlying":"Common Stock","underlying_shares":112.204},"source":{"system":"sec-edgar","filing":"0001209191-20-055261","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120055261/doc4.xml","form_type":"4"}},{"id":3014077,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-05T21:40:24.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":1007,"price":37.26,"value":37520.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person acquired these deferred shares under MetLife, Inc.'s non-management director compensation arrangements, which provide for 50% of non-management director retainer fees to be paid in MetLife, Inc. common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which directors may elect to defer receipt of such stock for a specified period of time."}],"balance_after":8121,"source":{"system":"sec-edgar","filing":"0001099219-20-000350","document":"wf-form4_160193400989121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921920000350/wf-form4_160193400989121.xml","form_type":"4"}},{"id":3030571,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-16T20:25:56.000Z","date":"2020-09-14","kind":"grant","acquired":true,"shares":83,"price":38.84,"value":3223.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents imputed reinvestment of dividends on deferred shares in the reporting person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred."}],"balance_after":7114,"source":{"system":"sec-edgar","filing":"0001099219-20-000312","document":"wf-form4_160028794144053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921920000312/wf-form4_160028794144053.xml","form_type":"4"}},{"id":388231,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2020-07-17T20:12:07.000Z","date":"2020-07-15","kind":"grant","acquired":true,"shares":26.275,"price":292.77,"value":7692.53175,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death."}],"balance_after":26.275,"derivative":{"underlying":"Common Stock","underlying_shares":26.275},"source":{"system":"sec-edgar","filing":"0001209191-20-042799","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120042799/doc4.xml","form_type":"4"}},{"id":3104424,"issuer":{"id":15437,"kind":"organization","name":"Change Healthcare Inc.","symbol":"CHNG"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-19T20:41:25.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":14486,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of deferred stock units that vests on June 17, 2021.  The shares subject to the units will be issued to the Reporting Person after the Reporting Person's separation from service from the Issuer."}],"balance_after":25912,"source":{"system":"sec-edgar","filing":"0001062993-20-002930","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754648/000106299320002930/form4.xml","form_type":"4"}},{"id":3105873,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-18T20:52:25.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":970,"price":38.69,"value":37529.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person acquired these deferred shares under MetLife, Inc.'s non-management director compensation arrangements, which provide for 50% of non-management director retainer fees to be paid in MetLife, Inc. common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which directors may elect to defer receipt of such stock for a specific period of time."}],"balance_after":7031,"source":{"system":"sec-edgar","filing":"0001099219-20-000275","document":"wf-form4_159251352832502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921920000275/wf-form4_159251352832502.xml","form_type":"4"}},{"id":3109557,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-16T21:00:14.000Z","date":"2020-06-12","kind":"grant","acquired":true,"shares":74,"price":37.45,"value":2771.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents imputed reinvestment of dividends on deferred shares in the reporting person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred."}],"balance_after":6061,"source":{"system":"sec-edgar","filing":"0001099219-20-000243","document":"wf-form4_159234119627548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921920000243/wf-form4_159234119627548.xml","form_type":"4"}},{"id":389652,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-05T21:39:51.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":1435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."}],"balance_after":1435,"source":{"system":"sec-edgar","filing":"0001209191-20-034747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120034747/doc4.xml","form_type":"4"}},{"id":3187283,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-02T21:23:17.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":1345,"price":27.9,"value":37525.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person acquired these deferred shares under MetLife, Inc.'s non-management director compensation arrangements, which provide for 50% of non-management director retainer fees to be paid in MetLife, Inc. common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which directors may elect to defer receipt of such stock for a specific period of time."}],"balance_after":5987,"source":{"system":"sec-edgar","filing":"0001099219-20-000186","document":"wf-form4_158586257947262.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921920000186/wf-form4_158586257947262.xml","form_type":"4"}},{"id":3206678,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-18T01:12:04.000Z","date":"2020-03-13","kind":"grant","acquired":true,"shares":63,"price":31.93,"value":2011.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents imputed reinvestment of dividends on deferred shares in the reporting person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred."}],"balance_after":4642,"source":{"system":"sec-edgar","filing":"0001099219-20-000156","document":"wf-form4_158449390692399.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921920000156/wf-form4_158449390692399.xml","form_type":"4"}},{"id":3319460,"issuer":{"id":488,"kind":"organization","name":"METLIFE INC","symbol":"MET"},"owners":[{"id":14718,"kind":"person","name":"MCKENZIE DIANA","position":1,"cik":"0001754648","reported_name":"MCKENZIE DIANA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T21:51:14.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":727,"price":51.62,"value":37527.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time."}],"balance_after":4579,"source":{"system":"sec-edgar","filing":"0001099219-20-000046","document":"wf-form4_157834745741825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921920000046/wf-form4_157834745741825.xml","form_type":"4"}}],"next_cursor":"2020-01-06T21:51:14.000000Z,3319460"}